Literature DB >> 22859830

Absence of the cystic fibrosis transmembrane regulator (Cftr) from myeloid-derived cells slows resolution of inflammation and infection.

T L Bonfield1, C A Hodges, C U Cotton, M L Drumm.   

Abstract

The absence or reduction of CFTR function causes CF and results in a pulmonary milieu characterized by bacterial colonization and unresolved inflammation. The ineffectiveness at controlling infection by species such as Pseudomonas aeruginosa suggests defects in innate immunity. Macrophages, neutrophils, and DCs have all been shown to express CFTR mRNA but at low levels, raising the question of whether CFTR has a functional role in these cells. Bone marrow transplants between CF and non-CF mice suggest that these cells are inherently different; we confirm this observation using conditional inactivation of Cftr in myeloid-derived cells. Mice lacking Cftr in myeloid cells overtly appear indistinguishable from non-CF mice until challenged with bacteria instilled into the lungs and airways, at which point, they display survival and inflammatory profiles intermediate in severity as compared with CF mice. These studies demonstrate that Cftr is involved directly in myeloid cell function and imply that these cells contribute to the pathophysiological phenotype of the CF lung.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22859830      PMCID: PMC3476241          DOI: 10.1189/jlb.0412188

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  54 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

Review 2.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

3.  Biochemical and functional characterization of three activated macrophage populations.

Authors:  Justin P Edwards; Xia Zhang; Kenneth A Frauwirth; David M Mosser
Journal:  J Leukoc Biol       Date:  2006-08-11       Impact factor: 4.962

Review 4.  The role of neutrophils and monocytes in innate immunity.

Authors:  Chahrazade Kantari; Magali Pederzoli-Ribeil; Véronique Witko-Sarsat
Journal:  Contrib Microbiol       Date:  2008

5.  Effect of Pseudomonas infection on weight loss, lung mechanics, and cytokines in mice.

Authors:  A M van Heeckeren; J Tscheikuna; R W Walenga; M W Konstan; P B Davis; B Erokwu; M A Haxhiu; T W Ferkol
Journal:  Am J Respir Crit Care Med       Date:  2000-01       Impact factor: 21.405

6.  Inflammatory cytokines in cystic fibrosis lungs.

Authors:  T L Bonfield; J R Panuska; M W Konstan; K A Hilliard; J B Hilliard; H Ghnaim; M Berger
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

7.  PU.1 regulation of human alveolar macrophage differentiation requires granulocyte-macrophage colony-stimulating factor.

Authors:  Tracey L Bonfield; Baisakhi Raychaudhuri; Anagha Malur; Susamma Abraham; Bruce C Trapnell; Mani S Kavuru; Mary Jane Thomassen
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2003-08-01       Impact factor: 5.464

8.  Role of granulocyte macrophage colony-stimulating factor during gram-negative lung infection with Pseudomonas aeruginosa.

Authors:  Megan N Ballinger; Robert Paine; Carlos H C Serezani; David M Aronoff; Esther S Choi; Theodore J Standiford; Galen B Toews; Bethany B Moore
Journal:  Am J Respir Cell Mol Biol       Date:  2006-02-10       Impact factor: 6.914

9.  The Th17 pathway in cystic fibrosis lung disease.

Authors:  Hui-Leng Tan; Nicolas Regamey; Sarah Brown; Andrew Bush; Clare M Lloyd; Jane C Davies
Journal:  Am J Respir Crit Care Med       Date:  2011-04-07       Impact factor: 21.405

Review 10.  The role of TLRs in neutrophil activation.

Authors:  Lynne R Prince; Moira K Whyte; Ian Sabroe; Lisa C Parker
Journal:  Curr Opin Pharmacol       Date:  2011-07-06       Impact factor: 5.547

View more
  60 in total

Review 1.  Fungal Pathogens in CF Airways: Leave or Treat?

Authors:  A Singh; A Ralhan; C Schwarz; D Hartl; A Hector
Journal:  Mycopathologia       Date:  2017-08-02       Impact factor: 2.574

2.  Interleukin-17 Pathophysiology and Therapeutic Intervention in Cystic Fibrosis Lung Infection and Inflammation.

Authors:  Daniel Hsu; Patricia Taylor; Dave Fletcher; Rolf van Heeckeren; Jean Eastman; Anna van Heeckeren; Pamela Davis; James F Chmiel; Eric Pearlman; Tracey L Bonfield
Journal:  Infect Immun       Date:  2016-08-19       Impact factor: 3.441

Review 3.  Salt, chloride, bleach, and innate host defense.

Authors:  Guoshun Wang; William M Nauseef
Journal:  J Leukoc Biol       Date:  2015-06-05       Impact factor: 4.962

4.  Partial Restoration of CFTR Function in cftr-Null Mice following Targeted Cell Replacement Therapy.

Authors:  Pascal Duchesneau; Rickvinder Besla; Mathieu F Derouet; Li Guo; Golnaz Karoubi; Amanda Silberberg; Amy P Wong; Thomas K Waddell
Journal:  Mol Ther       Date:  2017-02-08       Impact factor: 11.454

5.  The yin and yang of cystic fibrosis transmembrane conductance regulator function: implications for chronic lung disease.

Authors:  Neeraj Vij; Gregory P Downey
Journal:  Am J Respir Crit Care Med       Date:  2013-01-15       Impact factor: 21.405

6.  Mucus accumulation in the lungs precedes structural changes and infection in children with cystic fibrosis.

Authors:  Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher
Journal:  Sci Transl Med       Date:  2019-04-03       Impact factor: 17.956

7.  Ivacaftor-Induced Proteomic Changes Suggest Monocyte Defects May Contribute to the Pathogenesis of Cystic Fibrosis.

Authors:  Katherine B Hisert; Kelly Q Schoenfelt; Gordon Cooke; Brenda Grogan; Jan L Launspach; Charles G Gallagher; Seamas C Donnelly; Michael J Welsh; Pradeep K Singh; Edward F McKone; Lev Becker
Journal:  Am J Respir Cell Mol Biol       Date:  2016-04       Impact factor: 6.914

Review 8.  Modulating Innate and Adaptive Immunity by (R)-Roscovitine: Potential Therapeutic Opportunity in Cystic Fibrosis.

Authors:  Laurent Meijer; Deborah J Nelson; Vladimir Riazanski; Aida G Gabdoulkhakova; Geneviève Hery-Arnaud; Rozenn Le Berre; Nadège Loaëc; Nassima Oumata; Hervé Galons; Emmanuel Nowak; Laetitia Gueganton; Guillaume Dorothée; Michaela Prochazkova; Bradford Hall; Ashok B Kulkarni; Robert D Gray; Adriano G Rossi; Véronique Witko-Sarsat; Caroline Norez; Frédéric Becq; Denis Ravel; Dominique Mottier; Gilles Rault
Journal:  J Innate Immun       Date:  2016-03-18       Impact factor: 7.349

9.  A neutrophil intrinsic impairment affecting Rab27a and degranulation in cystic fibrosis is corrected by CFTR potentiator therapy.

Authors:  Kerstin Pohl; Elaine Hayes; Joanne Keenan; Michael Henry; Paula Meleady; Kevin Molloy; Bakr Jundi; David A Bergin; Cormac McCarthy; Oliver J McElvaney; Michelle M White; Martin Clynes; Emer P Reeves; Noel G McElvaney
Journal:  Blood       Date:  2014-06-16       Impact factor: 22.113

10.  Cystic fibrosis transmembrane conductance regulator recruitment to phagosomes in neutrophils.

Authors:  Yun Zhou; Kejing Song; Richard G Painter; Martha Aiken; Jakob Reiser; Bruce A Stanton; William M Nauseef; Guoshun Wang
Journal:  J Innate Immun       Date:  2013-03-06       Impact factor: 7.349

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.